Aquestive Therapeutics (AQST) Raw Materials (2017 - 2021)

Aquestive Therapeutics' Raw Materials history runs 5 years deep, the most recent figure standing at $833000.0 for Q1 2021.

• In Q1 2021, Raw Materials fell 35.18% year-over-year to $833000.0; the TTM figure through Mar 2021 stood at $833000.0 (down 35.18% YoY), while the FY2020 annual figure was $789000.0, down 36.58% from the prior year.
• Raw Materials was $833000.0 for Q1 2021 at Aquestive Therapeutics, up from $789000.0 in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $1.4 million in Q1 2019 to a low of $725000.0 in Q4 2017.
• Historically, Raw Materials has averaged $1.1 million across 5 years, with a median of $1.2 million in 2020.
• The sharpest annual moves came in 2018 and 2020: Raw Materials soared 76.97% in 2018, then slumped 36.58% in 2020.
• A 5-year view of Raw Materials shows it stood at $725000.0 in 2017, then surged by 76.97% to $1.3 million in 2018, then slipped by 3.04% to $1.2 million in 2019, then tumbled by 36.58% to $789000.0 in 2020, then rose by 5.58% to $833000.0 in 2021.
• The last three Raw Materials figures came in at $833000.0 (Q1 2021), $789000.0 (Q4 2020), and $1.2 million (Q3 2020), per Business Quant data.